Goodwill Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -41.31%
- Profit Growth 211.77%
- Ebitda 33.33%
- Net Worth 32.30%
- Total Assets -8.34%
About Goodwill Pharma
Goodwill Pharma Private Limited (GPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 December 2013 and has a history of 11 years and two months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anwarpasha Killare, Piraj Killare, and Valiahmed Killare serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74120MH2013PTC250819
- Company No.
250819
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Dec 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Goodwill Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anwarpasha Killare  | Director | 06-Dec-2013 | Current |
| Piraj Killare | Director | 06-Dec-2013 | Current |
| Valiahmed Killare | Director | 14-Nov-2018 | Current |
Financial Performance of Goodwill Pharma.
Goodwill Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 41.31% decrease. The company also saw a substantial improvement in profitability, with a 211.77% increase in profit. The company's net worth Soared by an impressive increase of 32.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Goodwill Pharma?
In 2019, Goodwill Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Marcos Security Force India Private LimitedPiraj Killare is a mutual person
Top Pharma Health Private LimitedAnwarpasha Killare and Piraj Killare are mutual person
- Goodwill Expert Facility India Llp
Piraj Killare is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Goodwill Pharma?
Unlock and access historical data on people associated with Goodwill Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Goodwill Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goodwill Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
